Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Eric Bouvier; Alan Marshall; and More

Premium

BG Medicine this week appointed Eric Bouvier as president and CEO. He replaces Pieter Muntendam, who has moved to the role of executive vice president and chief medical officer.

Bouvier was previously head of BioMérieux’s immunoassay business. Before that he was president of Leica Microsystems, a unit of Danaher.


Sera Prognostics this week appointed Jay Boniface vice president of research and development.

Boniface has worked as a scientist and program director at several biotech companies including Myriad Genetics, Myrexis, Prolexys, and Eos Biotechnology.


The Association of Biomolecular Resource Facilities this week named Alan Marshall winner of the ABRF Annual Award for Outstanding Contributions to Biomolecular Technologies.

Director of the National High Magnetic Field Laboratory ICR Program, Marshall is one of the inventors of Fourier transform ion cyclotron resonance mass spectrometry. He is a professor of chemistry and biochemistry at Florida State University

The award, which is sponsored by Waters, will be presented at the ABRF annual meeting in March.


Predictive Biosciences has appointed Angelo De Marzo as chief medical officer.

De Marzo previously was a faculty member at the Johns Hopkins University School of Medicine, where he was a professor of pathology, urology, and oncology and director of the Pathology Core for Specialized Cancer Research in prostate cancer. Also at Johns Hopkins, De Marzo was associate director of pathology cancer research at the Sidney Kimmel Comprehensive Cancer Center and director of the Tissue Microarray Core Facility.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.